Mehrandokht Abedini
Overview
Explore the profile of Mehrandokht Abedini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
168
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramezani Tehrani F, Sheidaei A, Rahmati M, Farzadfar F, Noroozzadeh M, Hosseinpanah F, et al.
BMJ Open Diabetes Res Care
. 2024 Jan;
11(6).
PMID: 38164706
Introduction: We evaluate which screening and diagnostic approach resulted in the greatest reduction in adverse pregnancy outcomes due to increased treatment. Research Design And Methods: This study presents a secondary...
2.
Ramezani Tehrani F, Farzadfar F, Hosseinpanah F, Rahmati M, Firouzi F, Abedini M, et al.
Front Endocrinol (Lausanne)
. 2023 Jun;
14:1155007.
PMID: 37334302
Objectives: The aim of the study was to investigate the effect of treatment on pregnancy outcomes among women who had fasting plasma glucose (FPG) 5.1-5.6 mmol/l in the first trimester...
3.
Ramezani Tehrani F, Rahmati M, Farzadfar F, Abedini M, Farahmand M, Hosseinpanah F, et al.
Front Endocrinol (Lausanne)
. 2023 Feb;
13:1039643.
PMID: 36818463
Objectives: There is considerable worldwide controversy regarding optimal screening and diagnostic approaches for GDM. This study aimed to compare the prevalence, maternal and neonatal outcomes of a One-step with a...
4.
Niknam A, Ramezani Tehrani F, Behboudi-Gandevani S, Rahmati M, Hedayati M, Abedini M, et al.
BMC Pregnancy Childbirth
. 2022 Oct;
22(1):764.
PMID: 36224521
Background: C-peptide offers potential as a marker to indicate childhood metabolic outcomes. Measuring C-peptide concentration might have better future utility in the risk stratification of neonates born to overweight or...
5.
Ramezani Tehrani F, Behboudi-Gandevani S, Farzadfar F, Hosseinpanah F, Hadaegh F, Khalili D, et al.
J Clin Endocrinol Metab
. 2022 Mar;
107(7):e2906-e2920.
PMID: 35325164
Context: Although it is well-acknowledged that gestational diabetes mellitus (GDM) is associated with the increased risks of adverse pregnancy outcomes, the optimal strategy for screening and diagnosis of GDM is...
6.
Shirzad M, Shakibazadeh E, Hajimiri K, Betran A, Jahanfar S, Bohren M, et al.
Reprod Health
. 2021 Jan;
18(1):3.
PMID: 33388072
Background: Cesarean section (CS) rates have been increasing globally. Iran has one of the highest CS rates in the world (47.9%). This review was conducted to assess the prevalence of...
7.
Shirzad M, Shakibazadeh E, Rahimi Foroushani A, Abedini M, Poursharifi H, Babaei S
Trials
. 2020 Nov;
21(1):970.
PMID: 33239038
Background: Cesarean section is an important surgical procedure, when normal vaginal delivery imposes a risk to mother and/or baby. The World Health Organization states the ideal rate for Cesarean section...
8.
Shirzad M, Shakibazadeh E, Betran A, Bohren M, Abedini M
Reprod Health
. 2019 Feb;
16(1):15.
PMID: 30736792
Background: Iran has one of the highest national caesarean section rates worldwide. Few studies explored in-depth the health-facility and health-system level factors that affect women's choices on mode of delivery...
9.
Alavian S, Ebrahimi E, Abedini M
Iran Red Crescent Med J
. 2017 Feb;
18(9):e40844.
PMID: 28144468
No abstract available.
10.
Abedini M, Ghaheri A, Omani Samani R
Int J Fertil Steril
. 2016 Oct;
10(3):283-289.
PMID: 27695610
Background: Due to the worldwide increase in infertility, it is both necessary and important to have assisted reproductive technology (ART) registries. In Iran, donation and surrogacy programs are approved by...